J. A. Kragten

842 total citations
18 papers, 242 citations indexed

About

J. A. Kragten is a scholar working on Cardiology and Cardiovascular Medicine, Organic Chemistry and Surgery. According to data from OpenAlex, J. A. Kragten has authored 18 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 2 papers in Organic Chemistry and 2 papers in Surgery. Recurrent topics in J. A. Kragten's work include Heart Failure Treatment and Management (4 papers), Cardiac Health and Mental Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). J. A. Kragten is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Cardiac Health and Mental Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). J. A. Kragten collaborates with scholars based in Netherlands, Australia and Austria. J. A. Kragten's co-authors include J. M. V. Mooij, Friedrich Fruhwald, Julie Hill, L.M.A.B. Van Bortel, Junren Zhu, Henry Krum, Hanneke Joosten, György Ábrahám, Carlos Poy and A F G Leentjens and has published in prestigious journals such as European Heart Journal, Drugs and Clinica Chimica Acta.

In The Last Decade

J. A. Kragten

18 papers receiving 225 citations

Peers

Countries citing papers authored by J. A. Kragten

Since Specialization

Citations

This map shows the geographic impact of J. A. Kragten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Kragten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Kragten more than expected).

Fields of papers citing papers by J. A. Kragten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Kragten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Kragten. The network helps show where J. A. Kragten may publish in the future.

Co-authorship network of co-authors of J. A. Kragten

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Kragten. A scholar is included among the top collaborators of J. A. Kragten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Kragten. J. A. Kragten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Successful lifestyle modification in older patients with coronary artery disease: results from the RESPONSE-2 trial 2020 ·European Heart Journal ·(unknown), H T Jørstad, Marjolein Snaterse, Gerben ter Riet, J. A. Kragten, (unknown), (unknown), S. Matthijs Boekholdt, Ron J.G. Peters, Wilma J.M. Scholte op Reimer	1
2	Effects of tailored telemonitoring on functional status and health-related quality of life in patients with heart failure 2019 ·Netherlands Heart Journal ·(unknown), Bram Ramaekers, Hans‐Peter Brunner‐La Rocca, (unknown), J. A. Kragten, Vanessa van Empel, (unknown), Hubertus JM Vrijhoef, Anton P.M. Gorgels, (unknown), Josiane Boyne, Christian Knackstedt	14
3	Effects of tailored telemonitoring on functional status and quality of life in patients with heart failure 2018 ·European Journal of Heart Failure ·(unknown), (unknown), (unknown), Hans‐Peter Brunner‐La Rocca, (unknown), J. A. Kragten, Vanessa van Empel, Hubertus JM Vrijhoef, Anton P.M. Gorgels, (unknown), Christian Knackstedt	1
4	Are premature ventricular contractions always harmless? 2013 ·European Journal of General Practice ·Ron Winkens, P. Höppener, J. A. Kragten, M. Verburg, Harry Crebolder	6
5	Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study) 2013 ·European Heart Journal ·Josiane Boyne, Antoinette D. I. van Asselt, Anton P.M. Gorgels, Lotte Steuten, J. A. Kragten, (unknown), Hubertus JM Vrijhoef	5
6	RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists 2009 ·Netherlands Heart Journal ·H T Jørstad, A. Marco Alings, Anho Liem, C. von Birgelen, Jan G.P. Tijssen, (unknown), Dirk J. Lok, J. A. Kragten, Ron J.G. Peters	12
7	1334 Telemonitoring in patients with heart failure: A feasibility study (TEHAF) 2008 ·European Journal of Cardiovascular Nursing ·Josiane Boyne, Hubertus JM Vrijhoef, Rianne de Wit, J. A. Kragten, (unknown), (unknown), (unknown), Hartmut Hengel, Anton P.M. Gorgels	5
8	[Complete atrioventricular block during galantamine therapy]. 2006 ·PubMed ·A F G Leentjens, J. A. Kragten	11
9	Tolerability of Beta-Blockers in Elderly Patients with Chronic Heart Failure: The COLA II Study 2005 ·European Journal of Heart Failure ·Henry Krum, Julie Hill, Friedrich Fruhwald, (unknown), György Ábrahám, Junren Zhu, Carlos Poy, J. A. Kragten	52
10	Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction. 1999 ·PubMed ·Jean‐Pierre Bassand, R Cariou, Gilles Grollier, J. A. Kragten, J.E. Wolf, Guy R. Heyndrickx	4
11	Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule 1998 ·Journal of Human Hypertension ·(unknown), (unknown), (unknown), J. A. Kragten, (unknown), (unknown)	18
12	Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins 1998 ·Clinica Chimica Acta ·K. W. H. Wodzig, J. A. Kragten, (unknown), J Górski, Marja P. van Dieijen‐Visser, Jan F. C. Glatz, Wim Th. Hermens	9
13	Right heart failure: Diagnosis via ultrasonography of the inferior vena cava and hepatic veins 1997 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·R Goei, (unknown), A.G.H. Kessels, J. A. Kragten	10
14	Heart failure: Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands 1996 ·European Heart Journal ·Bowine C. Michel, (unknown), Willem J. Remme, J.Herre Kingma, J. A. Kragten, (unknown), Ben A. van Hout	27
15	Comparison of Diltiazem Standard Formulation and Diltiazem Controlled Release in Patients with Stable Angina Pectoris 1993 ·Journal of Cardiovascular Pharmacology ·H.W. Vliegen, Ernst E. van der Wall, J. A. Kragten, (unknown), (unknown), (unknown), (unknown), Paul Mulder, A. V. G. Bruschke	15
16	Nebivolol in Hypertension 1993 ·Journal of Cardiovascular Pharmacology ·L.M.A.B. Van Bortel, (unknown), Hanneke Joosten, J. A. Kragten, (unknown), J. M. V. Mooij	44
17	Nebivolol in Hypertensive Patients 1991 ·Clinical Drug Investigation ·(unknown), Jan Joosten, (unknown), J. A. Kragten, (unknown), J. M. V. Mooij	2
18	Effect of Epanolol and Metoprolol on the Heart Measured by 24-Hour Holter Monitoring 1989 ·Drugs ·Adrie J.A.M. Withagen, (unknown), (unknown), J. A. Kragten, A. Vermeulen	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact